Skip to main content

Business

By Jessica Hagen | 12:03 pm | April 16, 2024
The Series C equity and debt financing round brings the company's total raise to $103 million. Two Chairs will use it to expand its reach nationally.  
By Trevor Dermody | 04:51 pm | April 15, 2024
The company plans to use the funds to further its AI development and create new hybrid solutions.
By Trevor Dermody | 01:33 pm | April 15, 2024
The New York-based startup will expand to 150 RAYUS locations across the U.S.   
By Trevor Dermody | 04:44 pm | April 12, 2024
The New York-based mental health company also announced a measurement-informed system to help providers transition to value-based care.
By Trevor Dermody | 04:53 pm | April 11, 2024
The company is launching Osso Health, a medical training app with workflows for common procedures hosted on Apple's augmented reality headset.
By Trevor Dermody | 03:14 pm | April 11, 2024
Augmedix's AI-enabled ambient automation will be integrated into Andor Health’s AI virtual consultation platform, ThinkAndor.
By Trevor Dermody | 03:53 pm | April 10, 2024
The companies plan to reduce burnout and support diagnosis efficiency through new AI-powered applications.  
By Trevor Dermody | 05:31 pm | April 09, 2024
Clinical-trial research company Clario announces new hire, and AI-enabled surgical care organization Apella and data company Brillio announce additions to their board of directors.  
By Trevor Dermody | 12:42 pm | April 09, 2024
The companies' joint offering, ThinkSono Guidance, attained Class IIb CE mark approval in March with upcoming plans for FDA approval.
By Trevor Dermody | 05:08 pm | April 08, 2024
Stock exchange rules give Amwell six months to comply with its minimum price requirement of $1 per share or be delisted. Amwell last traded above $1 in March.